JTE-451

N/A

Report date: 2025/03/13 20:00:06
NME

Base Information

Drug NameJTE-451
Drug Alias NameJTE-451JTE-451AJTE-451-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulatorsNuclear receptor ROR-gamma antagonists
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsPlaque psoriasisPsoriasisSkin Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJapan Tobacco (Hong Kong) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAkros Pharma Inc
Active IndicationsN/A
Inactive IndicationsPlaque psoriasisPsoriasisSkin Diseases

Other Information

ATC CodeN/A
Related LinksN/A